Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
59
VLTO Quote, Financials, Valuation and Earnings
Last price:
$102.99
Seasonality move
:
15.87%
Day range:
$99.57 - $101.00
52-week range:
$83.87 - $115.00
Dividend yield:
0.42%
P/E ratio:
28.72x
P/S ratio:
4.76x
P/B ratio:
10.82x
Volume:
1.3M
Avg. volume:
1.1M
1-year change:
1.32%
Market cap:
$24.9B
Revenue:
$5.2B
EPS (TTM):
$3.50
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.3B | $4.7B | $4.9B | $5B | $5.2B | |
| Revenue Growth (YoY) | -- | 8.1% | 3.62% | 3.1% | 3.43% | |
| Cost of Revenues | $1.8B | $2B | $2.1B | $2.1B | $2.1B | |
| Gross Profit | $2.5B | $2.7B | $2.8B | $2.9B | $3.1B | |
| Gross Profit Margin | 57.73% | 57.72% | 56.67% | 57.78% | 59.79% | |
| R&D Expenses | $219M | $244M | $217M | $225M | $253M | |
| Selling, General & Admin | $1.3B | $1.4B | $1.4B | $1.5B | $1.6B | |
| Other Inc / (Exp) | -$1M | $6M | $1M | -$14M | -$9M | |
| Operating Expenses | $1.6B | $1.7B | $1.6B | $1.8B | $1.9B | |
| Operating Income | $951M | $1B | $1.1B | $1.1B | $1.2B | |
| Net Interest Expenses | -- | -- | -- | $30M | $113M | |
| EBT. Incl. Unusual Items | $950M | $1B | $1.1B | $1.1B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $226M | $186M | $268M | $257M | $253M | |
| Net Income to Company | $724M | $861M | $845M | $839M | $833M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $724M | $861M | $845M | $839M | $833M | |
| Basic EPS (Cont. Ops) | $2.96 | $3.52 | $3.46 | $3.41 | $3.37 | |
| Diluted EPS (Cont. Ops) | $2.93 | $3.49 | $3.43 | $3.40 | $3.34 | |
| Weighted Average Basic Share | $244.5M | $244.5M | $244.5M | $246.4M | $247.3M | |
| Weighted Average Diluted Share | $246.7M | $246.7M | $246.7M | $246.8M | $249.6M | |
| EBITDA | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B | |
| EBIT | $951M | $1B | $1.1B | $1.1B | $1.2B | |
| Revenue (Reported) | $4.3B | $4.7B | $4.9B | $5B | $5.2B | |
| Operating Income (Reported) | $951M | $1B | $1.1B | $1.1B | $1.2B | |
| Operating Income (Adjusted) | $951M | $1B | $1.1B | $1.1B | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.2B | $1.2B | $1.3B | |
| Revenue Growth (YoY) | -- | -- | -- | 1.71% | 6.9% | |
| Cost of Revenues | -- | -- | $517M | $499M | $527M | |
| Gross Profit | -- | -- | $708M | $747M | $805M | |
| Gross Profit Margin | -- | -- | 57.8% | 59.95% | 60.44% | |
| R&D Expenses | -- | -- | $56M | $60M | $64M | |
| Selling, General & Admin | -- | -- | $360M | $394M | $419M | |
| Other Inc / (Exp) | -- | -- | -- | -$15M | -$6M | |
| Operating Expenses | -- | -- | $416M | $454M | $483M | |
| Operating Income | -- | -- | $292M | $293M | $322M | |
| Net Interest Expenses | -- | -- | -- | $28M | $27M | |
| EBT. Incl. Unusual Items | -- | -- | $292M | $250M | $289M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $67M | $66M | $64M | |
| Net Income to Company | -- | -- | $225M | $184M | $225M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $225M | $184M | $225M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.92 | $0.75 | $0.91 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.91 | $0.74 | $0.90 | |
| Weighted Average Basic Share | -- | -- | $244.5M | $246.9M | $247.9M | |
| Weighted Average Diluted Share | -- | -- | $246.7M | $248.8M | $250.1M | |
| EBITDA | -- | -- | $314M | $299M | $335M | |
| EBIT | -- | -- | $292M | $278M | $316M | |
| Revenue (Reported) | -- | -- | $1.2B | $1.2B | $1.3B | |
| Operating Income (Reported) | -- | -- | $292M | $293M | $322M | |
| Operating Income (Adjusted) | -- | -- | $292M | $278M | $316M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $5B | $5.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $2.1B | $2.1B | |
| Gross Profit | -- | -- | -- | $2.9B | $3.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $229M | $257M | |
| Selling, General & Admin | -- | -- | -- | $1.6B | $1.7B | |
| Other Inc / (Exp) | -- | -- | -- | -$29M | -- | |
| Operating Expenses | -- | -- | -- | $1.8B | $1.9B | |
| Operating Income | -- | -- | -- | $1.1B | $1.2B | |
| Net Interest Expenses | -- | -- | -- | $58M | $112M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $1.1B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $256M | $251M | |
| Net Income to Company | -- | -- | -- | $798M | $874M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $798M | $874M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $3.24 | $3.54 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $3.23 | $3.50 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $1.2B | $1.3B | |
| EBIT | -- | -- | -- | $1.1B | $1.2B | |
| Revenue (Reported) | -- | -- | -- | $5B | $5.3B | |
| Operating Income (Reported) | -- | -- | -- | $1.1B | $1.2B | |
| Operating Income (Adjusted) | -- | -- | -- | $1.1B | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.2B | $1.2B | $1.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $517M | $499M | $527M | |
| Gross Profit | -- | -- | $708M | $747M | $805M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $56M | $60M | $64M | |
| Selling, General & Admin | -- | -- | $360M | $394M | $419M | |
| Other Inc / (Exp) | -- | -- | -- | -$15M | -$6M | |
| Operating Expenses | -- | -- | $416M | $454M | $483M | |
| Operating Income | -- | -- | $292M | $293M | $322M | |
| Net Interest Expenses | -- | -- | -- | $28M | $27M | |
| EBT. Incl. Unusual Items | -- | -- | $292M | $250M | $289M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $67M | $66M | $64M | |
| Net Income to Company | -- | -- | $225M | $184M | $225M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $225M | $184M | $225M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.92 | $0.75 | $0.91 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.91 | $0.74 | $0.90 | |
| Weighted Average Basic Share | -- | -- | $244.5M | $246.9M | $247.9M | |
| Weighted Average Diluted Share | -- | -- | $246.7M | $248.8M | $250.1M | |
| EBITDA | -- | -- | $314M | $299M | $335M | |
| EBIT | -- | -- | $292M | $278M | $316M | |
| Revenue (Reported) | -- | -- | $1.2B | $1.2B | $1.3B | |
| Operating Income (Reported) | -- | -- | $292M | $293M | $322M | |
| Operating Income (Adjusted) | -- | -- | $292M | $278M | $316M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $762M | $1.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $757M | $816M | $826M | $812M | |
| Inventory | -- | $322M | $345M | $297M | $288M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $126M | $119M | $188M | $186M | |
| Total Current Assets | -- | $1.2B | $1.3B | $2.1B | $2.4B | |
| Property Plant And Equipment | -- | $260M | $247M | $262M | $268M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $2.5B | $2.5B | $2.5B | $2.7B | |
| Other Intangibles | -- | $533M | $479M | $427M | $535M | |
| Other Long-Term Assets | -- | $340M | $343M | $398M | $523M | |
| Total Assets | -- | $4.8B | $4.8B | $5.7B | $6.4B | |
| Accounts Payable | -- | $464M | $440M | $431M | $395M | |
| Accrued Expenses | -- | $227M | $211M | $184M | $244M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $34M | $32M | $33M | $39M | |
| Other Current Liabilities | -- | $158M | $177M | $270M | $253M | |
| Total Current Liabilities | -- | $1.1B | $1.1B | $1.3B | $1.2B | |
| Long-Term Debt | -- | -- | -- | $2.6B | $2.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $1.6B | $1.6B | $4.3B | $4.4B | |
| Common Stock | -- | $4.1B | $4.2B | $2M | $2M | |
| Other Common Equity Adj | -- | -$887M | -$954M | -$954M | -$1.1B | |
| Common Equity | -- | $3.2B | $3.2B | $1.4B | $2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $4M | $5M | $6M | $7M | |
| Total Equity | -- | $3.2B | $3.2B | $1.4B | $2B | |
| Total Liabilities and Equity | -- | $4.8B | $4.8B | $5.7B | $6.4B | |
| Cash and Short Terms | -- | -- | -- | $762M | $1.1B | |
| Total Debt | -- | -- | -- | $2.6B | $2.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $827M | $1.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $815M | $832M | |
| Inventory | -- | -- | -- | $308M | $310M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $167M | $177M | |
| Total Current Assets | -- | -- | -- | $2.1B | $2.6B | |
| Property Plant And Equipment | -- | -- | -- | $264M | $274M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $2.5B | $2.7B | |
| Other Intangibles | -- | -- | -- | $413M | $531M | |
| Other Long-Term Assets | -- | -- | -- | $415M | $544M | |
| Total Assets | -- | -- | -- | $5.7B | $6.6B | |
| Accounts Payable | -- | -- | -- | $402M | $407M | |
| Accrued Expenses | -- | -- | -- | $754M | $763M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $1.2B | $1.2B | |
| Long-Term Debt | -- | -- | -- | $2.6B | $2.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $4.2B | $4.3B | |
| Common Stock | -- | -- | -- | $2M | $2M | |
| Other Common Equity Adj | -- | -- | -- | -$981M | -$1B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $6M | $7M | |
| Total Equity | -- | -- | -- | $1.5B | $2.3B | |
| Total Liabilities and Equity | -- | -- | -- | $5.7B | $6.6B | |
| Cash and Short Terms | -- | -- | -- | $827M | $1.2B | |
| Total Debt | -- | -- | -- | $2.6B | $2.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $724M | $861M | $845M | $839M | $833M | |
| Depreciation & Amoritzation | $110M | $106M | $90M | $87M | $78M | |
| Stock-Based Compensation | $30M | $34M | $41M | $55M | $65M | |
| Change in Accounts Receivable | -$1M | -$14M | -$88M | $2M | $3M | |
| Change in Inventories | $12M | -$75M | -$38M | $52M | $3M | |
| Cash From Operations | $1B | $896M | $870M | $963M | $875M | |
| Capital Expenditures | $36M | $54M | $34M | $54M | $55M | |
| Cash Acquisitions | -$121M | -$34M | -$55M | -- | -$363M | |
| Cash From Investing | -$157M | -$97M | -$89M | -$55M | -$434M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$89M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $2.6B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$844M | -$800M | -$781M | -$147M | -- | |
| Other Financing Activities | -- | $1M | -- | -$2.6B | -- | |
| Cash From Financing | -$844M | -$799M | -$781M | -$135M | -$65M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $762M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $773M | $376M | |
| Ending Cash (CF) | -- | -- | -- | $762M | $1.1B | |
| Levered Free Cash Flow | $965M | $842M | $836M | $909M | $820M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $225M | $184M | $225M | |
| Depreciation & Amoritzation | -- | -- | $22M | $21M | $19M | |
| Stock-Based Compensation | -- | -- | $9M | $15M | $16M | |
| Change in Accounts Receivable | -- | -- | $1M | $4M | -$9M | |
| Change in Inventories | -- | -- | -$2M | -$13M | -$20M | |
| Cash From Operations | -- | -- | $156M | $115M | $157M | |
| Capital Expenditures | -- | -- | $9M | $13M | $15M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$9M | -$23M | -$11M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$22M | -$27M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$147M | -- | -- | |
| Cash From Financing | -- | -- | -$147M | -$20M | -$26M | |
| Beginning Cash (CF) | -- | -- | -- | $762M | $1.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$7M | $18M | |
| Additions / Reductions | -- | -- | -- | $72M | $120M | |
| Ending Cash (CF) | -- | -- | -- | $827M | $1.2B | |
| Levered Free Cash Flow | -- | -- | $147M | $102M | $142M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $798M | $874M | |
| Depreciation & Amoritzation | -- | -- | -- | $86M | $76M | |
| Stock-Based Compensation | -- | -- | $9M | $61M | $66M | |
| Change in Accounts Receivable | -- | -- | -- | $5M | -$10M | |
| Change in Inventories | -- | -- | -- | $41M | -$4M | |
| Cash From Operations | -- | -- | -- | $922M | $917M | |
| Capital Expenditures | -- | -- | $9M | $58M | $57M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$69M | -$422M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$22M | -$94M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -$8M | -$71M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $424M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $864M | $860M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $225M | $184M | $225M | |
| Depreciation & Amoritzation | -- | -- | $22M | $21M | $19M | |
| Stock-Based Compensation | -- | -- | $9M | $15M | $16M | |
| Change in Accounts Receivable | -- | -- | $1M | $4M | -$9M | |
| Change in Inventories | -- | -- | -$2M | -$13M | -$20M | |
| Cash From Operations | -- | -- | $156M | $115M | $157M | |
| Capital Expenditures | -- | -- | $9M | $13M | $15M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$9M | -$23M | -$11M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$22M | -$27M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$147M | -- | -- | |
| Cash From Financing | -- | -- | -$147M | -$20M | -$26M | |
| Beginning Cash (CF) | -- | -- | -- | $762M | $1.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$7M | $18M | |
| Additions / Reductions | -- | -- | -- | $72M | $120M | |
| Ending Cash (CF) | -- | -- | -- | $827M | $1.2B | |
| Levered Free Cash Flow | -- | -- | $147M | $102M | $142M | |
Get VLTO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VLTO
Sector
P/E ratio
28.72x
18.58x
PEG ratio
3.43x
0.25x
P/B ratio
10.82x
1.75x
Price / LTM sales
4.76x
0.94x
Growth Metrics
VLTO
Sector
Revenue growth
6.9%
1.98%
Earnings growth
21.62%
2.46%
Revenue (5-year growth)
--
4.35%
Earnings forecast
$0.88
$0.40
Profitability
VLTO
Sector
Profitability FY 2024
$3.1B
$393.9M
Return on invested capital
19.36%
5.32%
Return on assets
14.13%
3.49%
Return on equity
46.13%
8.55%
Earnings Date
Last Earnings Date
Apr
29
Next Earnings Date
Jul
28
Estimated Next Earnings Date
Jul
29
Balance Sheet
VLTO
Sector
Total cash
$1.2B
$154.3M
Short term investments
--
$35.5M
Total assets
$6.4B
$1.7B
Long term debt
$2.6B
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
